Anti-Inhibitor Coagulant Complex Prophylaxis in Hemophilia with Inhibitors
Author(s) -
Cindy A. Leissinger,
A. Gringeri,
Bülent Antmen,
Erik Berntorp,
Chiara Biasoli,
Shan L. Carpenter,
Paolo Angelo Cortesi,
HyeJin Jo,
Kaan Kavaklı,
Riitta Lassila,
Massimo Morfini,
Claude Négrier,
Angiola Rocino,
Wolfgang Schramm,
M. Şerban,
Marusia Valentina Uscatescu,
Jerzy Windyga,
Bülent Zülfikar,
LG Mantovani
Publication year - 2011
Publication title -
new england journal of medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 19.889
H-Index - 1030
eISSN - 1533-4406
pISSN - 0028-4793
DOI - 10.1056/nejmoa1104435
Subject(s) - medicine , factor ix , intensive care medicine , surgery
Patients with severe hemophilia A and factor VIII inhibitors are at increased risk for serious bleeding complications and progression to end-stage joint disease. Effective strategies to prevent bleeding in such patients have not yet been established.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom